F Barber
Plano, TXNPI 1366447120
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (48.7%), royalties or licence payments and speaking fees — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Depuy Synthes Products, Inc. at 38.4% of the total. Reporting peaked in 2019 at $83,435 and has fallen 88.2% since, to $9,813 in 2025.
Across 92 payments — averaging $2359.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Depuy Synthes Products, Inc.$83K
- Medical Device Business Services, Inc.$76K
- Pacira Pharmaceuticals Incorporated$28K
- Maruho Medical, Inc.$15K
- Arcuro Medical Inc$14K
- Smith+Nephew$165
- plus $145 from 3 others
What the payments were for
- Royalty or licence$83,21438%
- Consulting fees$105,75149%
- Speaking & faculty fees$18,0498%
- Travel & lodging$9,2884%
- Food & beverage$7710%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Depuy Synthes Products, Inc. | 29 | $83,408 |
| Medical Device Business Services, Inc. | 31 | $76,267 |
| Pacira Pharmaceuticals Incorporated | 16 | $28,467 |
| Maruho Medical, Inc. | 3 | $14,521 |
| Arcuro Medical Inc | 7 | $14,099 |
| Smith+Nephew | 2 | $165 |
| Johnson & Johnson | 2 | $103 |
| Zimmer Biomet | 1 | $24 |
| Abanza Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.